$21.27
-0.41-1.89%
At close: -
$21.27
0.000.00%
After Hours: 4:54 PM EDT
Castle Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Castle Biosciences using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-27 | $0.32 | $0.04 | 700.0 % |
Q3 | 2024-11-04 | $0.08 | $-0.06 | 233.3 % |
Q2 | 2024-08-05 | $0.31 | $-0.29 | 206.9 % |
Q1 | 2024-05-02 | $-0.09 | $-0.33 | 72.7 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-27 | $86.31M | $83.89M | 2.89 % |
Q3 | 2024-11-04 | $85.78M | $79.84M | 7.44 % |
Q2 | 2024-08-05 | $87.00M | $69.08M | 25.9 % |
Q1 | 2024-05-02 | $72.97M | $66.20M | 10.2 % |
Castle Biosciences (CSTL) is scheduled to report earnings on May 1, 2025. The last reported earnings were for reported on February 27, 2025 for Q4.
The Actual EPS was $0.32, which beat the estimate of $0.04.
The Actual Revenue was $86.3M, which beat the estimate of $83.9M.
Browse earnings estimates, EPS, and revenue on all stocks.